-
2026.06.30
EPS Group
EPS:Notice Regarding Business Restructuring and Trade Name Change of the Successor Company ー Weaving Data to Create New Value in Healthcareー
-
2025.12.12
Notice
Regarding the Recommendation of Surcharge Payment Order Against Our Former Employee
-
2025.09.26
News
GHG EMISSIONS FOR THE FISCAL YEAR ENDED SEPTEMBER 30,2024－FINAL FIGURES
-
2024.12.12
EPS Group
Presented as 9th International Conference on Vaccines Research & Development
-
2024.08.09
EPS Group
Notice on Reorganization
-
2024.05.09
News
EPS Holdings, Suzuken Group, and Bushu Pharmaceuticals Sign Partnership Agreement to Support the Introduction of Unapproved Drugs (Drug Loss Products) into the Japanese Market
-
2024.04.23
News
IRO Business Providing Total Business Solutions Starts on Full Scale
-Elimination of drug lag and drug loss, and support for foreign biotech companies entering the Japanese market-
-
2024.03.21
EPS Group
EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
-
2023.09.04
IR
EPS Group Overview of Results for the 32nd Fiscal Year Ended September 30, 2022
（334981）
-
2023.07.06
EPS Group
EPS Supported Important Japan-led International Investigator-Initiated HR+/HER2- Breast Cancer Study in Asia Pacific
-
2023.06.28
IR
Notice regarding acquisition of R&E Corporate Ltd (HK) and Taiga Supply Chain Management (Shenzhen) Co., Ltd. by EPS Creative Health Technology Group Limited
-
2023.04.27
News
Notice of EPS Group exhibiting at DIA2023 Global Annual Meeting and information about the promotional codes
-
2023.04.13
News
EPS Group supports Citeline Pharma Intelligence Awards Japan 2023 as a sponsor!
-
2023.03.10
IR
Notice Regarding Capital Alliance Between EPS Holdings, Inc. and Logos Science Co., Ltd. as Strategic Partners
-
2023.03.01
IR
Notice Regarding Investment of EPS Corporation in Helte Co., Ltd.
-
2023.02.13
IR
EPS Corporation signs agreement with Japan’s MHLW to develop operating environment and conduct surveys to promote Personal Health Records (PHRs)
-
2022.08.26
IR
Establishment of Intermediate Holding Company and Corporate Restructuring
（256514）
-
2022.07.04
IR
EP-SOGO and EPS International Announce Reorganization of SMO Taiwan
（216484）
-
2022.07.04
IR
EPS Group Forms Strategic Reorganization for CRO Business
（182948）
-
2022.06.02
News
EPS Holdings will be exhibiting at the DIA2022 Global Annual Meeting held in Chicago.
